Antibiotics

>

Latest News

FDA Approves Aztreonam and Avibactam for Complicated Intra-Abdominal Infections
FDA Approves Aztreonam and Avibactam for Complicated Intra-Abdominal Infections

February 7th 2025

This combination antibiotic is indicated for adults with limited or no treatment options, including gram-negative infections. It will be available in the third quarter of this year.

New Meta-Analysis Highlights Most Effective Treatments for Clostridioides difficile Infection
New Meta-Analysis Highlights Most Effective Treatments for Clostridioides difficile Infection

February 6th 2025

Levofloxacin for Preventing Multidrug-Resistant Tuberculosis
Levofloxacin for Preventing Multidrug-Resistant Tuberculosis

January 30th 2025

Intravenous Antimicrobials: Is It Time to Push?
Intravenous Antimicrobials: Is It Time to Push?

January 29th 2025

FDA Decisions to Watch Q1-Q2: Infectious Disease
FDA Decisions to Watch Q1-Q2: Infectious Disease

January 28th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.